Avadel Pharmaceuticals Receives Orphan Drug Designation from FDA for LUMRYZ™ (sodium oxybate) for Extended-Release Oral Suspension for the Treatment of Idiopathic Hypersomnia

9th June 2025

Home Category Drug Development FDA Approvals

FDA Approvals

Cystic Fibrosis Treatment Approved By European Commission

17th January 2022

There is currently no cure for cystic fibrosis (CF), a debilitating, progressive condition with over 10,830 people in the UK...

New lung cancer treatment combo approved on NHS in England

by Content Team

17th January 2022

Catalent and Zumutor Biologics Collaborate to Manufacture First-in-Class mAb to Treat Solid Tumors

A new treatment for some people with a type of non small cell lung cancer (NSCLC) will now be routinely...

Pfizer and BioNTech Receive U.S. FDA EUA of COVID-19 Vaccine Booster for Individuals 12 Years of Age and Older

by Content Team

8th January 2022

Pfizer, Moderna & AstraZeneca - Their COVID-19 vaccine comparison

Pfizer Inc. and BioNTech SE announced that the U.S. FDA has expanded the EUA of a booster dose of the...

WuXi STA’s Shanghai Facility Gets FDA Nod Post Inspection

by Content Team

7th January 2022

WuXi AppTec’s WuXi STA has said that its facility at Waigaoqiao near Shanghai has cleared its first FDA drug product...

WuXi STA Passes the First U.S. FDA Drug Product Pre-Approval Inspection at its Shanghai Waigaoqiao site

by Content Team

4th January 2022

WuXi STA Passes the First U.S. FDA Drug Product Pre-Approval Inspection at its Shanghai Waigaoqiao site

WuXi STA – a subsidiary of WuXi AppTec, announced that its Waigaoqiao site in Shanghai, China, successfully passed the first...

FDA clears AstraZeneca’s Covid antibody treatment for immunocompromised

by Content Team

14th December 2021

AstraZeneca agrees to supply Europe with 400 million doses of COVID-19 vaccine

The FDA authorized the first injectable monoclonal antibody cocktail for long-term prevention of Covid-19 among people with weakened immune systems...

Actemra/RoActemra approved by the European Commission to treat patients with severe COVID-19

by Content Team

14th December 2021

Johnson & Johnson COVID-19 Vaccine Authorized by U.S. FDA For Emergency Use

Roche announced that the European Commission has extended the marketing authorisation for Actemra®/RoActemra® (tocilizumab) to include the treatment of COVID-19...

CHMP Recommends EU Approval of Regeneron Antibody Cocktail to Treat and Prevent COVID-19

by Content Team

19th November 2021

CHMP Recommends EU Approval of Regeneron Antibody Cocktail to Treat and Prevent COVID-19

Regeneron Pharmaceuticals, Inc. announced that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted...

Johnson & Johnson COVID-19 Vaccine Booster Shot Authorized for Emergency Use by U.S. FDA

by Content Team

26th October 2021

Johnson & Johnsons's single-dose COVID-19 vaccine gets approval for emergency use in India

Johnson & Johnson announced the U.S. FDA has issued EUA for a booster dose of the Johnson & Johnson COVID-19...

Moderna Announces FDA Authorization of a Booster Dose of Moderna’s COVID-19 Vaccine in the U.S.

by Content Team

21st October 2021

Moderna Announces the EC's Approval of Advance Purchase Agreement for Initial 80 Million Doses of mRNA Vaccine Against COVID-19

Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, announced that the U.S. FDA has authorized for...

Page 11 of 28 Prev 1 … 10 11 12 … 28 Next

Merck to Acquire Verona Pharma in $10B Deal Boosts COPD Drug

Emerging Oral Small-Molecule Drugs for Ultra-Rare Diseases

FDA Approves Oral Therapy for Treating Hereditary Angioedema

Avadel Pharmaceuticals Receives Orphan Drug Designation from FDA for LUMRYZ™ (sodium oxybate) for Extended-Release Oral Suspension for the Treatment of Idiopathic Hypersomnia

Robots and AI in Drug Discovery Are Transforming Medicine

Stringent Policy around COVID Vaccines Laid by FDA

Pharmaceutical Chemicals Market Booms with Rising API Demand

Next in Pharma 2025: Innovations Shaping the Future

Work Smart: Go for Hands-Free Lab Informatics at the Bench, Not Scribbled Notes and Delayed Documentation at Your Desk

Merck to Acquire Verona Pharma in $10B Deal Boosts COPD Drug

Emerging Oral Small-Molecule Drugs for Ultra-Rare Diseases

FDA Approves Oral Therapy for Treating Hereditary Angioedema

Avadel Pharmaceuticals Receives Orphan Drug Designation from FDA for LUMRYZ™ (sodium oxybate) for Extended-Release Oral Suspension for the Treatment of Idiopathic Hypersomnia

Robots and AI in Drug Discovery Are Transforming Medicine

Stringent Policy around COVID Vaccines Laid by FDA

Pharmaceutical Chemicals Market Booms with Rising API Demand

Next in Pharma 2025: Innovations Shaping the Future

Work Smart: Go for Hands-Free Lab Informatics at the Bench, Not Scribbled Notes and Delayed Documentation at Your Desk

FDA Approves Oral Therapy for Treating Hereditary Angioedema

Avadel Pharmaceuticals Receives Orphan Drug Designation from FDA for LUMRYZ™ (sodium oxybate) for Extended-Release Oral Suspension for the Treatment of Idiopathic Hypersomnia

FDA Approvals

Cystic Fibrosis Treatment Approved By European Commission

New lung cancer treatment combo approved on NHS in England

Pfizer and BioNTech Receive U.S. FDA EUA of COVID-19 Vaccine Booster for Individuals 12 Years of Age and Older

WuXi STA’s Shanghai Facility Gets FDA Nod Post Inspection

WuXi STA Passes the First U.S. FDA Drug Product Pre-Approval Inspection at its Shanghai Waigaoqiao site

FDA clears AstraZeneca’s Covid antibody treatment for immunocompromised

Actemra/RoActemra approved by the European Commission to treat patients with severe COVID-19

CHMP Recommends EU Approval of Regeneron Antibody Cocktail to Treat and Prevent COVID-19

Johnson & Johnson COVID-19 Vaccine Booster Shot Authorized for Emergency Use by U.S. FDA

Moderna Announces FDA Authorization of a Booster Dose of Moderna’s COVID-19 Vaccine in the U.S.

Qucik Links

About Us

Subscribe Us

System

Resources

Retrieve your password